Mark Singleton is the Senior Vice President and Chief Financial Officer at Bioventus Class A Inc., a leading medical device company focused on developing and commercializing innovative treatments that engage and enhance the body's natural healing process. With over two decades of experience in finance and healthcare, Singleton has been instrumental in guiding Bioventus through its growth and expansion phases. Before joining Bioventus, Singleton held various senior financial positions at other prominent healthcare companies. He served as the Vice President of Finance at Wright Medical Group, where he played a key role in the company's financial strategy and operations. Prior to that, he worked at PricewaterhouseCoopers, where he honed his skills in auditing and financial consulting. Singleton's extensive background in finance and healthcare has equipped him with the expertise necessary to navigate the complex financial landscape of the medical device industry. As the Chief Financial Officer at Bioventus, Singleton is responsible for overseeing the company's financial planning, reporting, and investor relations. His strategic vision and leadership have been crucial in driving Bioventus' financial performance and supporting its mission to deliver innovative solutions to patients worldwide. Under his guidance, Bioventus has successfully navigated challenges and achieved significant milestones, solidifying its position as a leader in the regenerative medicine market.